non-covalent Nrf2 activators (Biogen)

N/A

Report date: 2025/01/26 17:37:24
NME

Base Information

Drug Namenon-covalent Nrf2 activators (Biogen)
Drug Alias Namenon-covalent nuclear factor erythroid 2-related factor 2 activators (Biogen)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor erythroid 2-related factor 2 stimulants
TargetsNuclear factor erythroid 2-related factor 2
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiogen Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiogen Inc
Inactive CompaniesN/A
Active IndicationsNerve Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A